Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
TransMedics Group, Inc. (TMDX) had Operating Cash Flow per Share of $-0.07 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$143.54M |
|
$25.68M |
|
$55.31M |
|
$88.23M |
|
$116.09M |
|
$27.44M |
|
$-0.77M |
|
$26.68M |
|
$26.68M |
|
$25.68M |
|
$25.68M |
|
$25.68M |
|
$25.68M |
|
$27.44M |
|
$33.58M |
|
33.72M |
|
39.91M |
|
$0.76 |
|
$0.70 |
|
| Balance Sheet Financials | |
$505.92M |
|
$311.24M |
|
$331.61M |
|
$837.53M |
|
$55.60M |
|
$510.10M |
|
$515.62M |
|
$571.22M |
|
$266.31M |
|
$252.66M |
|
$266.31M |
|
33.83M |
|
| Cash Flow Statement Financials | |
$-2.85M |
|
$-27.04M |
|
$3.03M |
|
$337.15M |
|
$310.64M |
|
$-26.51M |
|
$8.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.10 |
|
-- |
|
-- |
|
0.66 |
|
1.92 |
|
61.47% |
|
19.12% |
|
19.12% |
|
-- |
|
18.58% |
|
17.89% |
|
$-29.89M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
1.27 |
|
1.01 |
|
89.05 |
|
9.64% |
|
10.16% |
|
3.07% |
|
3.31% |
|
$7.87 |
|
$-0.75 |
|
|
Operating Cash Flow per Share |
$-0.07 |